Drreddys Laboratories reported INR16.84B in Operating Profit for its fiscal quarter ending in June of 2025.


Operating Profit Change Date
ANI Pharmaceuticals USD 15.17M 11.02M Jun/2025
Aurora Cannabis CAD -20220000 56.44M Jun/2025
Bayer EUR 13M 2.31B Jun/2025
Canopy Growth CAD -22080000 1.74M Jun/2025
Cipla INR 15.25B 2.97B Jun/2025
Corcept Therapeutics USD 26.67M 23.26M Jun/2025
Drreddys Laboratories INR 16.84B 1.88B Jun/2025
GlaxoSmithKline GBP 2.02B 193M Jun/2025
Hikma Pharmaceutical USD 282M 45M Dec/2024
Lonza CHF 430M 104M Dec/2024
Novartis USD 4.86B 201M Jun/2025
Pacira USD 10.23M 8.24M Jun/2025
Prestige Brands USD 71.76M 16.67M Jun/2025
Richter Gedeon HUF 63.71B 2.25B Sep/2024
Sun Pharmaceuticals INR 33.72B 9.73B Jun/2025
Supernus Pharmaceuticals USD 12.14M 14.74M Jun/2025
Teva Pharmaceutical Industries USD 899M 380M Jun/2025